Home›Companies›Healthcare›Lura Health

UCHU Biosensors, Inc.

Lura Health develops mouth-worn sensors for real-time health monitoring.

Updated Nov 17, 2026·Latest SEC filing Nov 17, 2026·Suggest an edit

About Lura Health

Lura Health helps people monitor their health from inside the mouth. It develops small, wearable sensors that provide real-time readings.

UCHU Biosensors uses Lura Health as its brand. It is based in Newark, New Jersey, and Daniel Weinstein is chief executive officer. In 2017, its four-person Tufts team won the Stephen and Geraldine Ricci Interdisciplinary Prize.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 25, 2026Nov 17, 2026$1,332,668of $6.0M target10$133KEquityRule 506(b)Form D ↗
Jul 6, 2022Jul 14, 2022$828,360of $5.2M target18$46,020EquityRule 506(b)Form D ↗
Total, two offerings$2,161,028

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Lura Health's Form D filed Nov 17, 2026.

DW
Daniel Weinstein
CEO and director
On every Form D that Lura Health has filed: 2 filings, from Jul 14, 2022 to Nov 17, 2026.
JK
Jeremy Krell
Director
First appears on the Form D that Lura Health filed on November 17, 2026; on 1 of its 2 filings.
SB
Saam Bozorg
Executive officer and director
On every Form D that Lura Health has filed: 2 filings, from Jul 14, 2022 to Nov 17, 2026.
SK
Shunsuke Koide
Director
First appears on the Form D that Lura Health filed on November 17, 2026; on 1 of its 2 filings.

Earlier filings also listed

  • Noah Hill · executive officer and director
    Last listed on the Form D that Lura Health filed on July 14, 2022; on 1 of its 2 filings.

Who Invested in Lura Health

Scroll table to see all columns →

AnnouncedRoundAmountLeadOther investorsOn the Form DSource
Aug 7, 2026Follow-on investmentUndisclosed—ReturningSCO Group.[2][1]
Aug 5, 2025Strategic investmentUndisclosed—SCO Group[6]

Announced amounts can differ from Form D figures: an announcement can combine several closings, and some money is raised without a Form D.

Why Investors Backed Lura Health

SCO Group sees Lura Health's intraoral sensing as a base for combining AI, testing and data in a broader oral health platform. It backed the company again to speed that build after a 2025 strategic investment and business partnership. [1][6]

Origin and Team

In 2017, UCHU's Tufts team included Daniel Weinstein and Camila Menard, both E18. Noah Hill (E20) and Saam Bozorg (D1) completed the four-person group. [3]

Product and Technology

Lura Health's wearable microsensors sit inside the mouth and can attach to dental appliances. The company combines microelectronics with biosignal processing for real-time health monitoring. [6][3]

Use of Funds

  • The follow-on investment will speed development of an oral health platform combining intraoral sensing, AI, testing and data. [1]

Milestones

Scroll table to see all columns →

DateWhat happenedSourceCoverage
Aug 5, 2025Lura Health announced a business partnership with SCO Group to advance intraoral health monitoring.[6]—
Feb 28, 2022The National Science Foundation awarded Lura Health a $1 million Phase II Small Business Innovation Research grant.[7]—
Nov 15, 2017UCHU Biosensors and Tarseer won the Stephen and Geraldine Ricci Interdisciplinary Prize at Tufts.[3]—

We wrote this summary from public statements by Lura Health and its investors. It is not investment advice.

Sources

  1. InvestorSCO Group news: additional investment in Lura Health
  2. InvestorSCO Group follow-on investment release
  3. ResearchTufts Gordon Institute: UCHU Biosensors wins Ricci prize
  4. SECLura Health Form D, filed 2026-11-17 · linked above ↑
  5. SECLura Health Form D, filed 2022-07-14 · linked above ↑
  6. AnnouncementLura Health strategic investment and partnership release
  7. Sourcebusinesswire.com
  8. SECUCHU Biosensors, Inc. filing history